Compact but mighty: Biology and applications of type III-E CRISPR-Cas systems

Jurre A. Steens; John van der Oost; Raymond H.J. Staals

doi:10.1016/j.molcel.2022.11.007

Compact but mighty: Biology and applications of type III-E CRISPR-Cas systems

Jurre A. Steens, John van der Oost, Raymond H.J. Staals^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

2 Citations (Scopus)

Abstract

In this issue, Liu et al. present an in-depth study aiming to unravel the structural, biochemical, and physiological aspects of how type III-E CRISPR-Cas systems trigger abortive infection by activating a protease upon target RNA recognition.¹

Original language	English
Pages (from-to)	4405-4406
Journal	Molecular Cell
Volume	82
Issue number	23
DOIs	https://doi.org/10.1016/j.molcel.2022.11.007
Publication status	Published - 1 Dec 2022

Access to Document

10.1016/j.molcel.2022.11.007

Cite this

@article{dffdff41ede94bdd9c99af0829e98478,

title = "Compact but mighty: Biology and applications of type III-E CRISPR-Cas systems",

abstract = "In this issue, Liu et al. present an in-depth study aiming to unravel the structural, biochemical, and physiological aspects of how type III-E CRISPR-Cas systems trigger abortive infection by activating a protease upon target RNA recognition.1",

author = "Steens, \{Jurre A.\} and \{van der Oost\}, John and Staals, \{Raymond H.J.\}",

year = "2022",

month = dec,

day = "1",

doi = "10.1016/j.molcel.2022.11.007",

language = "English",

volume = "82",

pages = "4405--4406",

journal = "Molecular Cell",

issn = "1097-2765",

publisher = "Elsevier",

number = "23",

}

TY - JOUR

T1 - Compact but mighty

T2 - Biology and applications of type III-E CRISPR-Cas systems

AU - Steens, Jurre A.

AU - van der Oost, John

AU - Staals, Raymond H.J.

PY - 2022/12/1

Y1 - 2022/12/1

N2 - In this issue, Liu et al. present an in-depth study aiming to unravel the structural, biochemical, and physiological aspects of how type III-E CRISPR-Cas systems trigger abortive infection by activating a protease upon target RNA recognition.1

AB - In this issue, Liu et al. present an in-depth study aiming to unravel the structural, biochemical, and physiological aspects of how type III-E CRISPR-Cas systems trigger abortive infection by activating a protease upon target RNA recognition.1

U2 - 10.1016/j.molcel.2022.11.007

DO - 10.1016/j.molcel.2022.11.007

M3 - Comment/Letter to the editor

AN - SCOPUS:85142456746

SN - 1097-2765

VL - 82

SP - 4405

EP - 4406

JO - Molecular Cell

JF - Molecular Cell

IS - 23

ER -

Compact but mighty: Biology and applications of type III-E CRISPR-Cas systems

Abstract

Access to Document

Fingerprint

Cite this